AlzChem Group AG (ETR:ACT)
Germany
· Delayed Price · Currency is EUR 149.00
-7.60 (-4.85%)
At close: Feb 27, 2026
AlzChem Group AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 562.12 | 554.23 | 540.65 | 542.22 | 422.29 | Upgrade
|
| Other Revenue | 23.34 | 9.21 | 5.14 | 7.31 | 7.11 | Upgrade
|
| Revenue | 585.46 | 563.44 | 545.79 | 549.53 | 429.41 | Upgrade
|
| Revenue Growth (YoY) | 3.91% | 3.23% | -0.68% | 27.97% | 11.22% | Upgrade
|
| Cost of Revenue | 182.25 | 214.97 | 241.72 | 279.26 | 171.1 | Upgrade
|
| Gross Profit | 403.21 | 348.47 | 304.07 | 270.27 | 258.3 | Upgrade
|
| Selling, General & Admin | 173.61 | 164.29 | 149.35 | 138.68 | 133.03 | Upgrade
|
| Other Operating Expenses | 113.12 | 82.92 | 75 | 76.87 | 63.97 | Upgrade
|
| Operating Expenses | 313.38 | 273.52 | 250.26 | 241.09 | 221.47 | Upgrade
|
| Operating Income | 89.83 | 74.95 | 53.81 | 29.17 | 36.84 | Upgrade
|
| Interest Expense | -5.13 | -2.66 | -4.36 | -1.64 | -1 | Upgrade
|
| Interest & Investment Income | 3.24 | 2.21 | 0.35 | 8.21 | 0.63 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 0.82 | -1.64 | 0.1 | 0.03 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | 5.23 | - | Upgrade
|
| EBT Excluding Unusual Items | 87.94 | 75.32 | 48.16 | 41.08 | 36.5 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 0.02 | 0.03 | 0.21 | 0.02 | Upgrade
|
| Pretax Income | 87.94 | 75.34 | 48.19 | 41.28 | 36.51 | Upgrade
|
| Income Tax Expense | 24.31 | 21.1 | 13.4 | 11.06 | 8.75 | Upgrade
|
| Earnings From Continuing Operations | 63.63 | 54.25 | 34.79 | 30.22 | 27.76 | Upgrade
|
| Minority Interest in Earnings | -0.17 | -0.17 | -0.17 | -0.17 | -0.17 | Upgrade
|
| Net Income | 63.46 | 54.08 | 34.62 | 30.05 | 27.59 | Upgrade
|
| Net Income to Common | 63.46 | 54.08 | 34.62 | 30.05 | 27.59 | Upgrade
|
| Net Income Growth | 17.35% | 56.19% | 15.20% | 8.91% | 40.11% | Upgrade
|
| Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 10 | Upgrade
|
| Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 10 | Upgrade
|
| Shares Change (YoY) | -0.67% | 0.05% | 0.33% | -0.11% | -0.29% | Upgrade
|
| EPS (Basic) | 6.28 | 5.31 | 3.40 | 2.96 | 2.72 | Upgrade
|
| EPS (Diluted) | 6.28 | 5.31 | 3.40 | 2.96 | 2.72 | Upgrade
|
| EPS Growth | 18.14% | 56.12% | 14.82% | 9.03% | 40.52% | Upgrade
|
| Free Cash Flow | 39.22 | 62.05 | 52.11 | -33.31 | 14.48 | Upgrade
|
| Free Cash Flow Per Share | 3.88 | 6.10 | 5.13 | -3.29 | 1.43 | Upgrade
|
| Dividend Per Share | - | 1.800 | 1.200 | 1.050 | 1.000 | Upgrade
|
| Dividend Growth | - | 50.00% | 14.29% | 5.00% | 29.87% | Upgrade
|
| Gross Margin | 68.87% | 61.85% | 55.71% | 49.18% | 60.15% | Upgrade
|
| Operating Margin | 15.34% | 13.30% | 9.86% | 5.31% | 8.58% | Upgrade
|
| Profit Margin | 10.84% | 9.60% | 6.34% | 5.47% | 6.43% | Upgrade
|
| Free Cash Flow Margin | 6.70% | 11.01% | 9.55% | -6.06% | 3.37% | Upgrade
|
| EBITDA | 116.48 | 98.44 | 77.08 | 51.96 | 58.66 | Upgrade
|
| EBITDA Margin | 19.89% | 17.47% | 14.12% | 9.46% | 13.66% | Upgrade
|
| D&A For EBITDA | 26.65 | 23.49 | 23.26 | 22.79 | 21.83 | Upgrade
|
| EBIT | 89.83 | 74.95 | 53.81 | 29.17 | 36.84 | Upgrade
|
| EBIT Margin | 15.34% | 13.30% | 9.86% | 5.31% | 8.58% | Upgrade
|
| Effective Tax Rate | 27.64% | 28.00% | 27.80% | 26.79% | 23.96% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.